• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
	Q3-CY2026	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014
Balance Sheet Date			2026-Apr-30	2026-Jan-31	2025-Oct-31	2025-Jul-31	2025-Apr-30	2025-Jan-31
Fiscal Period			Q4-FY2026	Q3-FY2026	Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025
Close Price of Common Stock	24.30$	25.45$	19.91$	26.53$	23.74$	16.69$	24.85$
Market Cap of Common Stock	1,424,040,677$	1,485,601,834$	1,161,921,591$	1,548,000,376$	1,221,400,518$	857,009,069$
QoQ%	(4.14%)	27.86%	(24.94%)	26.74%	42.52%
YoY%	16.59%	73.35%
Common Shares Outstanding		58,602,497	58,383,924	58,349,053	51,449,053	51,348,656	51,348,656	100	19,909,281	19,909,281	105,808
QoQ%		.37%	.06%	13.41%	.20%	.00%	51,348,556.00%	(100.00%)	.00%	18,716.42%
YoY%		14.13%	13.70%	58,348,953.00%	158.42%	157.91%	48,430.03%
Price to Sales	14.97x	15.62x	12.21x	18.49x	16.45x	12.91x
Price to Earnings	-	-	-	-	-	-
Price to Book	5.48x	5.72x	4.47x	5.38x	7.44x	4.65x
Total Revenue			28,638,000$	24,552,000$	22,565,000$	19,371,000$	17,233,000$	15,090,000$	14,710,000$	12,782,000$
QoQ%			16.64%	8.81%	16.49%	12.41%	14.20%	2.58%	15.08%
YoY%			66.18%	62.70%	53.40%	51.55%
TTM			95,126,000$	83,721,000$	74,259,000$	66,404,000$	59,815,000$
TTM_QoQ%			13.62%	12.74%	11.83%	11.02%
TTM_YoY%			59.03%
Gross Margin			54.76%	52.57%	50.63%	45.69%	44.29%	43.39%	39.63%	32.86%
QoQ			2.19%	1.94%	4.94%	1.40%	.91%	3.75%	6.77%
YoY			10.47%	9.18%	10.99%	12.83%
Operating Income			(39,344,000$)	(34,765,000$)	(31,755,000$)	(28,878,000$)	(48,212,000$)	(20,601,000$)	(19,134,000$)	(18,431,000$)
QoQ%			(13.17%)	(9.48%)	(9.96%)	40.10%	(134.03%)	(7.67%)	(3.81%)
YoY%			18.39%	(68.75%)	(65.96%)	(56.68%)
TTM			(134,742,000$)	(143,610,000$)	(129,446,000$)	(116,825,000$)	(106,378,000$)
TTM_QoQ%			6.18%	(10.94%)	(10.80%)	(9.82%)
TTM_YoY%			(26.66%)
Operating Margin			(137.38%)	(141.60%)	(140.73%)	(149.08%)	(279.77%)	(136.52%)	(130.08%)	(144.20%)
QoQ			4.21%	(.87%)	8.35%	130.69%	(143.25%)	(6.45%)	14.12%
YoY			142.38%	(5.08%)	(10.65%)	(4.88%)
Net Income			(38,835,000$)	(34,166,000$)	(32,785,000$)	(25,826,000$)	(51,111,000$)	(21,759,000$)	(20,621,000$)	(20,323,000$)
QoQ%			(13.67%)	(4.21%)	(26.95%)	49.47%	(134.90%)	(5.52%)	(1.47%)
YoY%			24.02%	(57.02%)	(58.99%)	(27.08%)
TTM			(131,612,000$)	(143,888,000$)	(131,481,000$)	(119,317,000$)	(113,814,000$)
TTM_QoQ%			8.53%	(9.44%)	(10.20%)	(4.84%)
TTM_YoY%			(15.64%)
Profit Margin			(135.61%)	(139.16%)	(145.29%)	(133.32%)	(296.59%)	(144.20%)	(140.18%)	(159.00%)
QoQ			3.55%	6.13%	(11.97%)	163.27%	(152.39%)	(4.01%)	18.81%
YoY			160.98%	5.04%	(5.11%)	25.67%
Equity to Common Shareholders			259,658,000$	287,989,000$	164,081,000$	184,159,000$	205,406,000$	(257,895,000$)	(236,545,000$)	(216,471,000$)	(209,377,000$)
QoQ			(28,331,000$)	123,908,000$	(20,078,000$)	(21,247,000$)	463,301,000$	(21,350,000$)	(20,074,000$)	(7,094,000$)
QoQ%			(9.84%)	75.52%	(10.90%)	(10.34%)	179.65%	(9.03%)	(9.27%)	(3.39%)
YoY			54,252,000$	545,884,000$	400,626,000$	400,630,000$	414,783,000$
YoY%			26.41%	211.67%	169.37%	185.07%	198.10%
Dividends Paid
Additional Paid-In Capital QoQ
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets			358,465,000$	379,342,000$	246,701,000$	266,296,000$	295,744,000$				45,949,000$
QoQ			(20,877,000$)	132,641,000$	(19,595,000$)	(29,448,000$)
YoY			62,721,000$				249,795,000$
Total Liabilities			98,807,000$	91,353,000$	82,620,000$	82,137,000$	90,338,000$				78,216,000$
QoQ			7,454,000$	8,733,000$	483,000$	(8,201,000$)
YoY			8,469,000$				12,122,000$
Current Ratio			4.41x	7.32x	5.47x	6.84x	6.72x				.45x
Total Current Assets			222,359,000$	314,063,000$	195,414,000$	220,691,000$	255,328,000$				14,907,000$
QoQ			(91,704,000$)	118,649,000$	(25,277,000$)	(34,637,000$)
Total Current Liabilities			50,372,000$	42,931,000$	35,756,000$	32,256,000$	37,977,000$				32,971,000$
QoQ			7,441,000$	7,175,000$	3,500,000$	(5,721,000$)
Debt to Asset Ratio			.28x	.24x	.33x	.31x	.31x				1.70x
Long Term Debt			42,649,000$	42,261,000$	41,873,000$	41,486,000$	41,098,000$				42,536,000$
QoQ			388,000$	388,000$	387,000$	388,000$
YoY			1,551,000$				(1,438,000$)
Capital Lease Obligations			4,142,000$	1,585,000$			3,213,000$
Cash and Cash Equivalents			99,710,000$	291,321,000$	175,424,000$	201,214,000$	237,595,000$	54,352,000$	76,918,000$	99,969,000$	8,249,000$
QoQ			(191,611,000$)	115,897,000$	(25,790,000$)	(36,381,000$)	183,243,000$	(22,566,000$)	(23,051,000$)	91,720,000$
YoY			(137,885,000$)	236,969,000$	98,506,000$	101,245,000$	229,346,000$
Interest Expenses
Interest Income			2,226,000$	2,163,000$	1,796,000$	2,167,000$	1,656,000$	628,000$	878,000$	37,000$

Copy Table ✓